The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
The Immunomodulatory Effects of Macrolides—A Systematic Review of the Underlying Mechanisms
Open accessAbstract
Background: The mechanisms underlying the non-antimicrobial immunomodulatory properties of macrolides are not well understood. Objectives: To systematically review the evidence for the immunomodulatory properties of macrolides in humans and to describe the underlying mechanism and extent of their influence on the innate and adaptive immune system. Methods: A systematic literature search was done in MEDLINE using the OVID interface from 1946 to December 2016 according to the preferred reporting items for systematic reviews and meta-analysis (PRISMA). Original articles investigating the influence of four macrolides (azithromycin, clarithromycin, erythromycin, and roxithromycin) on immunological markers in humans were included. Results: We identified 22 randomized, controlled trials, 16 prospective cohort studies, and 8 case-control studies investigating 47 different immunological markers (186 measurements) in 1,834 participants. The most frequently reported outcomes were a decrease in the number of neutrophils, and the concentrations of neutrophil elastase, interleukin (IL)-8, IL-6, IL-1beta, tumor necrosis factor (TNF)-alpha, eosinophilic cationic protein, and matrix metalloproteinase 9. Inhibition of neutrophil function was reported more frequently than eosinophil function. A decrease in T helper (Th) 2 cells cytokines (IL-4, IL-5, IL-6) was reported more frequently than a decrease in Th1 cytokines (IL-2, INF-gamma). Conclusion: Macrolides influence a broad range of immunological mechanisms resulting in immunomodulatory effects. To optimize the treatment of chronic inflammatory diseases by macrolides, further studies are necessary, particularly comparing different macrolides and dose effect relationships.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gotzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · BMJ · doi:10.1136/bmj.b2700 · Cited by 17,648
The pharmacokinetics of azithromycin in human serum and tissues
Foulds, G., Shepard, R. M., & Johnson, R. B. (1990) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/25.suppl_a.73 · Cited by 755
Azithromycin: Mechanisms of action and their relevance for clinical applications
Parnham, M. J., Haber, V. E., Giamarellos-Bourboulis, E. J., Perletti, G., Verleden, G. M., & Vos, R. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.03.003 · Cited by 661
Wong, C., Jayaram, L., Karalus, N., Eaton, T., Tong, C., Hockey, H., Milne, D., Fergusson, W., Tuffery, C., Sexton, P., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60953-2 · Cited by 600
Improvement of Survival in Patients with Diffuse Panbronchiolitis Treated with Low-dose Erythromycin
KUDOH, S., AZUMA, A., YAMAMOTO, M., IZUMI, T., & ANDO, M. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.6.9710075 · Cited by 582
Equi, A., Balfour-Lynn, I., Bush, A., & Rosenthal, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11081-6 · Cited by 543
Clarithromycin Targets Neutrophilic Airway Inflammation in Refractory Asthma
Simpson, J. L., Powell, H., Boyle, M. J., Scott, R. J., & Gibson, P. G. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200707-1134oc · Cited by 482
Brusselle, G. G., VanderStichele, C., Jordens, P., Deman, R., Slabbynck, H., Ringoet, V., Verleden, G., Demedts, I. K., Verhamme, K., Delporte, A., et al. (2013) · Thorax · doi:10.1136/thoraxjnl-2012-202698 · Cited by 477
Retsema, J., Girard, A., Schelkly, W., Manousos, M., Anderson, M., Bright, G., Borovoy, R., Brennan, L., & Mason, R. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.12.1939 · Cited by 464
Tenson, T., Lovmar, M., & Ehrenberg, M. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00662-4 · Cited by 461
Wallwork, B., Coman, W., Mackay‐Sim, A., Greiff, L., & Cervin, A. (2006) · The Laryngoscope · doi:10.1097/01.mlg.0000191560.53555.08 · Cited by 350
Mycoplasma pneumoniae and Chlamydia pneumoniae in Asthma
Kraft, M., Cassell, G. H., Pak, J., & Martin, R. J. (2002) · Chest · doi:10.1378/chest.121.6.1782 · Cited by 335
Macrolide antibiotics for cystic fibrosis
Southern, K. W., Barker, P. M., Solis-Moya, A., & Patel, L. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002203.pub4 · Cited by 298
Clement, A. (2006) · Thorax · doi:10.1136/thx.2005.057950 · Cited by 292
Čulić, O., Eraković, V., Čepelak, I., Barišić, K., Brajša, K., Ferenčić, Ž., Galović, R., Glojnarić, I., Manojlović, Z., Munić, V., et al. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02042-3 · Cited by 234
Clinical Pharmacokinetics of Clarithromycin
Rodvold, K. A. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199937050-00003 · Cited by 214
Kew, K. M., Undela, K., Kotortsi, I., & Ferrara, G. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002997.pub4 · Cited by 208
Macrolides and ketolides: azithromycin, clarithromycin, telithromycin
Zuckerman, J. M. (2004) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2004.04.010 · Cited by 207
Tissue-directed pharmacokinetics
Schentag, J. J., & Ballow, C. H. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90394-d · Cited by 200
Sakito, O., Kadota, J.-I., Kohno, S., Abe, K., Shirai, R., & Hara, K. (1996) · Respiration · doi:10.1159/000196514 · Cited by 184
Macrolide Treatment Decreased the Size of Nasal Polyps and IL-8 Levels in Nasal Lavage
Yamada, T., Fujieda, S., Mori, S., Yamamoto, H., & Saito, H. (2000) · American Journal of Rhinology · doi:10.2500/105065800782102717 · Cited by 167
Anti-Inflammatory Effects Of Antimicrobial Agents: An In Vivo Study
Plewig, G., & Schöpf, E. (1975) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12610281 · Cited by 163
Amayasu, H., Yoshida, S., Ebana, S., Yamamoto, Y., Nishikawa, T., Shoji, T., Nakagawa, H., Hasegawa, H., Nakabayashi, M., & Ishizaki, Y. (2000) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)62409-x · Cited by 161
Vascular endothelial growth factor in human periodontal disease
Booth, V., Young, S., Cruchley, A. T., Taichman, N. S., & Paleolog, E. M. (1998) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.1998.tb02349.x · Cited by 151
Ratjen, F. A., Saiman, L. M., Mayer-Hamblett, N., Lands, L. C., Kloster, M., Thompson, V., Emmett, P., Marshall, B. C., Accurso, F. J., Sagel, S. D., et al. (2012) · CHEST Journal · doi:10.1378/chest.12-0628 · Cited by 123
Anti-inflammatory effects of azithromycin in cystic fibrosis airway epithelial cells
Cigana, C., Nicolis, E., Pasetto, M., Assael, B. M., & Melotti, P. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.09.132 · Cited by 121
He, Z., Ou, L.-M., Zhang, J., Bai, J., Liu, G., Li, M., Deng, J., MacNee, W., & Zhong, X. (2010) · Respiration · doi:10.1159/000321374 · Cited by 120
PIACENTINI, G. L., Peroni, D. G., Bodini, A., Pigozzi, R., Costella, S., Loiacono, A., & Boner, A. L. (2007) · Allergy and Asthma Proceedings · doi:10.2500/aap.2007.28.2958 · Cited by 116
Yalçın, E., Ki̇per, N., Özçelik, U., Doğru, D., Fırat, P., Sahin, A., Ariyurek, M. O., Mocan, G., Gürcan, N., & Göçmen, A. (2006) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2006.00708.x · Cited by 108
Cervin, A., Kalm, O., Sandkull, P., & Lindberg, S. I. (2002) · Otolaryngology · doi:10.1067/mhn.2002.124849 · Cited by 102
Interventions for bronchiectasis: an overview of Cochrane systematic reviews
Welsh, E. J., Evans, D. J., Fowler, S. J., & Spencer, S. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010337.pub2 · Cited by 99
Parnham, M. J., Čulić, O., Haber, V. E., Kos, V. M., Popović‐Grle, S., Barišić, K., Bosnar, M., Brajša, K., Čepelak, I., Čužić, S., et al. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.05.023 · Cited by 95
Fonseca-Aten, M., Okada, P. J., Bowlware, K. L., Chávez‐Bueno, S., Mejías, A., Rios, A. M., Katz, K., Olsen, K. D., Ng, S., Jafri, H. S., et al. (2006) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)60935-0 · Cited by 73
Suzuki, H., Shimomura, A., Ikeda, K., Oshima, T., & Takasaka, T. (1997) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.182.115 · Cited by 72
Zhang, L., Su, Z., Zhang, Z., Lin, J., Li, D.-Q., & Pflugfelder, S. C. (2015) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2015.2326 · Cited by 71
Azithromycin for Bronchial Asthma in Adults: An Effectiveness Trial
Hahn, D. L., Grasmick, M., Hetzel, S., Yale, S. H., & on behalf of the AZMATICS (AZithroMycin-Asthma Trial In Community Settings) Study Group (2012) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2012.04.110309 · Cited by 69
Wallwork, B. D., Coman, W. B., Mackay‐Sim, A., & Cervin, A. (2004) · The Laryngoscope · doi:10.1097/00005537-200402000-00019 · Cited by 57
Azithromycin inhibits IL-1 secretion and non-canonical inflammasome activation
Gualdoni, G. A., Lingscheid, T., Schmetterer, K. G., Hennig, A., Steinberger, P., & Zlabinger, G. J. (2015) · Scientific Reports · doi:10.1038/srep12016 · Cited by 56
Effect of clarithromycin on acute asthma exacerbations in children: an open randomized study
Koutsoubari, I., Papaevangelou, V., Konstantinou, G. Ν., Makrinioti, H., Xepapadaki, P. V., Kafetzis, D. A., & Papadopoulos, N. G. (2012) · Pediatric Allergy and Immunology · doi:10.1111/j.1399-3038.2012.01280.x · Cited by 47
Anti-inflammatory Activity of Azithromycin as Measured by Its NF-кB Inhibitory Activity
Cheung, P. S., Si, E. C., & Hosseini, K. (2010) · Ocular Immunology and Inflammation · doi:10.3109/09273940903359725 · Cited by 39
Liu, J., Zhong, X., He, Z., Wei, L.-H., Zheng, X., Zhang, J., Bai, J., Zhong, W., & Zhong, D. (2014) · Mediators of Inflammation · doi:10.1155/2014/708608 · Cited by 38
Cervin, A., Wallwork, B. D., Mackay‐Sim, A., Coman, W. B., & Greiff, L. (2008) · Clinical Physiology and Functional Imaging · doi:10.1111/j.1475-097x.2008.00848.x · Cited by 36
Kobayashi, M., Shimauchi, T., Hino, R., et al. (2004) · Cellular Immunology · doi:10.1016/j.cellimm.2004.03.011 · Cited by 33
Perić, A. V., Vojvodić, D., & Matkovic, S. (2012) · The Journal of Laryngology & Otology · doi:10.1017/s0022215112000485 · Cited by 32
Azithromycin Decreases Crevicular Fluid Volume and Mediator Content
Ho, W., Eubank, T. D., Leblebicioğlu, B., Marsh, C. B., & Walters, J. D. (2010) · Journal of Dental Research · doi:10.1177/0022034510368650 · Cited by 31
Fouka, E., Lamprianidou, E., Arvanitidis, K. I., Filidou, E., Kolios, G. C., Miltiades, P., Paraskakis, E., Antoniadis, A. P., Kotsianidis, Ι., & Bouros, D. E. (2014) · Lung · doi:10.1007/s00408-014-9619-0 · Cited by 30
Clarithromycin therapy for patients with Cystic Fibrosis: A randomized controlled trial
Robinson, P. J., Schechter, M. S., Sly, P. D., Winfield, K., Smith, J. C., Brennan, S., Shinkai, M., Henke, M. O., & Rubin, B. K. (2012) · Pediatric Pulmonology · doi:10.1002/ppul.21613 · Cited by 27
Effects of azithromycin on ozone-induced airway neutrophilia and cytokine release
Criqui, G. I., Solomon, C., Welch, B. S., et al. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.15e08.x · Cited by 20
Perić, A., Vojvodić, D., Baletić, N., PERİĆ, A., & Miljanović, O. (2010) · Biomedical Papers · doi:10.5507/bp.2010.049 · Cited by 18
Roxithromycin inhibits chemokine-induced chemotaxis of Th1 and Th2 cells but regulatory T cells
Ito, T., Ito, N., Hashizume, H., & Takigawa, M. (2009) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2009.01.007 · Cited by 14
Doğru, D., Dalgiç, F., Kiper, N., Özçelik, U., Yalçın, E., Aslan, A. T., Gürcan, N., Sarıcaoğlu, F., Gür, D., Karayazgan, Y., et al. (2009) · PubMed · Cited by 14
Vergleich der Gewebegängigkeit von Erythromycin
Dette, G. A. (1979) · Infection · doi:10.1007/bf01641314 · Cited by 13
Sadreddini, S., Noshad, H., Molaeefard, M., MOLOUDI, R., Ardalan, M., & Ghojazadeh, M. (2009) · International Journal of Rheumatic Diseases · doi:10.1111/j.1756-185x.2009.01379.x · Cited by 7
Cited by
A single-cell atlas of the peripheral immune response in patients with severe COVID-19
Wilk, A. J., Rustagi, A., Zhao, N. Q., Roque, J., Martínez-Colón, G. J., McKechnie, J. L., Ivison, G. T., Ranganath, T., Vergara, R., Hollis, T., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0944-y · Cited by 1,493
Abaleke, E., Abbas, M., Abbasi, S., Abbott, A., Abdelaziz, A., Abdelbadiee, S., Abdelfattah, M., Abdul, B., Abdul Rasheed, A., Abdul-Kadir, R., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00149-5 · Cited by 533
Furtado, R. H. M., Berwanger, O., Fonseca, H. A., Corrêa, T. D., Ferraz, L. R., Lapa, M. G., Zampieri, F. G., Veiga, V. C., Azevedo, L. C. P., Rosa, R. G., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31862-6 · Cited by 360
Atri, D., Siddiqi, H. K., Lang, J. P., Nauffal, V., Morrow, D. A., & Bohula, E. A. (2020) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2020.04.002 · Cited by 321
Ong, T., & Ramsey, B. W. (2023) · JAMA · doi:10.1001/jama.2023.8120 · Cited by 315
Metadata
- Authors
- Zimmermann, P., Ziesenitz, V. C., Curtis, N., & Ritz, N.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2018-03-13
- Volume
- 9
- Pages
- 302-302
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2791163322
- Cited by
- 303
- References
- 54
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.